Position in BDSX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$649,353
+$344,829 QoQ
Shares Held
44,783
0.0% QoQ
Ownership
0.443%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#13
of 40 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 97.90322220485453.ToString("F0")%
Shared 0.ToString("F0")%
None 2.096777795145479.ToString("F0")%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PERKINS CAPITAL MANAGEMENT INC holds $23,879,825 across 9 Diagnostics & Research names. BDSX ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
44,300 | $8,859,557 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,450,333 | |
| 3 | MDXH |
MDxHealth SA
|
1,476,441 | $3,395,814 | |
| 4 | VCYT |
Veracyte, Inc.
|
75,333 | $2,426,475 | |
| 5 | PSNL |
Personalis, Inc.
|
239,000 | $1,522,430 | |
| 6 | NEO |
Neogenomics Inc
|
132,350 | $982,037 | |
| 7 | BDSX |
Biodesix Inc
This page
|
44,783 | $649,353 | |
| 8 | CSTL |
Castle Biosciences Inc
|
15,415 | $378,438 |
All Filings in BDSX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $649,353 | 44,783 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $304,524 | 44,783 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $397,379 | 52,633 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||